Reading the tape
NASDAQ: JYNT
The Joint Corp.
Healthcare · Medical - Care Facilities
Market Cap
$124.38M
52w High
$13.47
52w Low
$7.50
P/E
43.51
Volume
36.83K
Outstanding Shares
14.32M
Price vs Fundamentals
Why The Stock Is Moving
Likely multiple compressionModerate confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: -12.07%Revenue (TTM): 228.55%FCF (TTM): -95.93%P/E: 10th pct
What changed
The stock fell 12.07% over the last year. Revenue grew 228.55% over the trailing twelve months. Operating margin moved from -9.3% to -1.65%. Free cash flow declined 95.93% over the trailing twelve months.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price, and the shares now sit around the 10th percentile of their historical P/E range. That looks more like a rerating of the multiple than a collapse in the business.
What would invalidate this read
This read changes if operating margin (currently -1.65%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics.
CEOSanjiv Razdan
SectorHealthcare
IndustryMedical - Care Facilities
Employees443
IPO dateNov 11, 2014
Valuation
Forward P/E—
EV/EBITDA58.07
Enterprise value$110.38M
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth-139.62%
Gross margin76.56%▼1.75%vs FY2024
Operating margin-1.65%▲54.45%vs FY2024
ROE19.31%▲168.80%vs FY2024
Analyst consensus
RatingBuy
Target price$20.00▲130.31%
5
Buy
3
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 7, 2026
Q2 FY26 · EPS est $0.03 · Revenue est $14.5M
View